{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:33:30Z","timestamp":1779114810314,"version":"3.51.4"},"reference-count":14,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Blau syndrome (BS), is an autoinflammatory granulomatosis disease characterized by a distinct triad of skin, joint, and eye disorders similar to those of sarcoidosis, but the lung involvement frequently observed in sarcoidosis are rare. Granulomas from patients with BS displayed a distinct morphology indicating an exuberant chronic inflammatory response. Patients with BS may have granulomatous lung lesions, which require early diagnosis. To determine whether therapeutic intervention is needed for lung lesions, examining transbronchial lung cryobiopsy specimens and accumulating cases of BS with lung involvement could be contributed to improving BS management in the future.<\/jats:p>","DOI":"10.3389\/fmed.2024.1380236","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T04:26:04Z","timestamp":1718166364000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Pulmonary granulomas confirmed in Blau syndrome using TBLC specimens: Case report"],"prefix":"10.3389","volume":"11","author":[{"given":"Yasuo","family":"Shimizu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitomo","family":"Kushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayae","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Takemasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyuki","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Niho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,6,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/s0022-3476(85)80394-2","article-title":"Familial granulomatous arthritis, iritis, and rash.","volume":"107","author":"Blau","year":"1985","journal-title":"J Pediatr"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1136\/annrheumdis-2020-217320","article-title":"Clinical characteristics and treatment of 50 cases of Blau syndrome in Japan confirmed by genetic analysis of the NOD2 mutation.","volume":"79","author":"Matsuda","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1002\/art.22509","article-title":"Interstitial pneumonitis in Blau syndrome with documented mutation in CARD15.","volume":"56","author":"Becker","year":"2007","journal-title":"Arthritis Rheum"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.jaci.2012.02.004","article-title":"Morphologic and immunohistochemical characterization of granulomas in the nucleotide oligomerization domain 2-related disorders Blau syndrome and Crohn disease.","volume":"129","author":"Janssen","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B5","year":"2020","journal-title":"Guide to Sarcoidosis Clinical Practice."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/216056","article-title":"A case of blau syndrome.","volume":"2014","author":"Chauhan","year":"2014","journal-title":"Case Rep Rheumatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/art.24134","article-title":"Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis.","volume":"60","author":"Okafuji","year":"2009","journal-title":"Arthritis Rheum"},{"key":"B8","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1165\/rcmb.2016-0375TR","article-title":"The role of nucleotide-binding oligomerization domain-like receptors in pulmonary infection.","volume":"57","author":"Wiese","year":"2017","journal-title":"Am J Respir Cell Mol Biol."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-021-00505-5","article-title":"A novel mutation in early-onset sarcoidosis\/Blau syndrome: an association with Propionibacterium acnes.","volume":"19","author":"Okazaki","year":"2021","journal-title":"Pediatr Rheumatol Online J"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e27612","article-title":"Advance in pathogenesis of sarcoidosis: triggers and progression.","volume":"10","author":"Chen","year":"2024","journal-title":"Heliyon"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.895765","article-title":"Potential Benefits of TNF targeting therapy in Blau syndrome, a NOD2-associated systemic autoinflammatory granulomatosis.","volume":"13","author":"Matsuda","year":"2022","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1211240","article-title":"Tofacitinib, a suppressor of NOD2 expression, is a potential treatment for Blau syndrome.","volume":"14","author":"Ueki","year":"2023","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8091327","article-title":"Role of bronchoscopic techniques in the diagnosis of thoracic sarcoidosis.","volume":"8","author":"Pedro","year":"2019","journal-title":"J Clin Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"00203","DOI":"10.1183\/23120541.00203-2019","article-title":"Diagnostic yield and safety of transbronchial cryobiopsy in sarcoidosis.","volume":"5","author":"Jacob","year":"2019","journal-title":"ERJ Open Res"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1380236\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T04:26:05Z","timestamp":1718166365000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1380236\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,12]]},"references-count":14,"alternative-id":["10.3389\/fmed.2024.1380236"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1380236","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,12]]},"article-number":"1380236"}}